These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26100010)

  • 21. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.
    Huang JW; Lin WF; Yang JM
    Vaccine; 2012 Sep; 30(44):6327-37. PubMed ID: 22885274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
    Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
    Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational analysis of the receptor binding specificity of novel influenza A/H7N9 viruses.
    Zhou X; Zheng J; Ivan FX; Yin R; Ranganathan S; Chow VTK; Kwoh CK
    BMC Genomics; 2018 May; 19(Suppl 2):88. PubMed ID: 29764421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a Novel Universal Potential Epitope on the Cytoplasmic Tail of H7N9 Virus Hemagglutinin.
    Liu X; Ding L; Yuan J; Liao J; Duan L; Wang W; Tan W; Yu W; Zhou B; Chen X; Yang Z
    Virol Sin; 2019 Jun; 34(3):334-337. PubMed ID: 31016481
    [No Abstract]   [Full Text] [Related]  

  • 26. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation of the hemagglutinin of avian influenza virus H9N2.
    Song XF; Han P; Chen YP
    J Med Virol; 2011 May; 83(5):838-46. PubMed ID: 21412792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus.
    Wang X; Sun Q; Ye Z; Hua Y; Shao N; Du Y; Zhang Q; Wan C
    Exp Ther Med; 2016 Oct; 12(4):2439-2446. PubMed ID: 27703505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.
    Koel BF; Burke DF; Bestebroer TM; van der Vliet S; Zondag GC; Vervaet G; Skepner E; Lewis NS; Spronken MI; Russell CA; Eropkin MY; Hurt AC; Barr IG; de Jong JC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA; Smith DJ
    Science; 2013 Nov; 342(6161):976-9. PubMed ID: 24264991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genomic sequences of human infection of avian-origin influenza A(H7N9)virus in Zhejiang province].
    Chen Y; Mao HY; Li Z; Xu CP; Gao J; Feng Y; Wang XY; Yan JY; Zhang YJ; Lu YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jun; 34(6):604-8. PubMed ID: 24125614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
    Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
    J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first lack of evidence of H7N9 avian influenza virus infections among pigs in Eastern China.
    Zhao FR; Zhou DH; Lin T; Shao JJ; Wei P; Zhang YG; Chang HY
    Microb Pathog; 2015 Mar; 80():63-6. PubMed ID: 25680835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of common epitopes on hemagglutinin of the influenza A virus (H1 subtype).
    Guo C; Xie X; Li H; Zhao P; Zhao X; Sun J; Wang H; Liu Y; Li Y; Hu Q; Hu J; Li Y
    Exp Mol Pathol; 2015 Feb; 98(1):79-84. PubMed ID: 25533547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China.
    Fang Q; Gao Y; Chen M; Guo X; Yang X; Yang X; Wei L
    Infect Genet Evol; 2014 Aug; 26():228-40. PubMed ID: 24911284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).
    Chu DH; Sakoda Y; Nishi T; Hiono T; Shichinohe S; Okamatsu M; Kida H
    Vaccine; 2014 Jun; 32(28):3473-9. PubMed ID: 24793949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptive evolution of a novel avian-origin influenza A/H7N9 virus.
    Arunachalam R
    Genomics; 2014 Dec; 104(6 Pt B):545-53. PubMed ID: 25449177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proof-of-principle study to identify suitable vaccine seed candidates to combat introductions of Eurasian lineage H5 and H7 subtype avian influenza viruses.
    Beato MS; Monne I; Mancin M; Bertoli E; Capua I
    Avian Pathol; 2010 Oct; 39(5):375-82. PubMed ID: 20954014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?
    Rudenko L; Isakova-Sivak I; Rekstin A
    Expert Rev Vaccines; 2014 Jan; 13(1):1-4. PubMed ID: 24308582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.